|
Tertiary:
Secondary:
|
|
MAO-A:
MAO-B:
|
|
|
|
|
|
|
|
|
|
|
|
|
Most of the drugs increase [NA] and [5-HT] at the central synapses.
14-21 days- onset of action
3-5 weeks- clinical response
Multipotent actions on numerous monoaminergic receptors due to non- specific increase in 5-Ht or NA.
|
TAD’s |
SSRI’s |
Efficacy |
|
|
Side effects |
Antimuscarinic:
Alpha-lytic:
|
|
Safety |
Narrow therapeutic window at relatively low doses, therefore drug overdose potential. |
Overdose potential. Venlafaxine toxicity:
|
Is a NaSSA: NA and specific serotonin AD. Blockade of a2, 5-HT 2A & 5- HT3. Also blocks H1, a1 and indirect stimulation of 5-HT 1A.
Blocks both 5-HT and NA re-uptake more potent for 5-HT than for NA.
Antagonist: 5-HT 2c
Agonist: Melatonergic receptors- MT1 and MT 2